Digital Health Startups

CoupleWise offers a guided, app-based relationship program built on couples counseling methods and relationship research, using a 5-step process around 24 identified relationship needs to help partners improve communication, resolve conflict, and increase intimacy. It is aimed at couples seeking a private, at-home alternative to traditional in-person therapy.

1 investor

Gastrocare Partners operates a network of gastrointestinal practices in the western United States, bringing together established clinical practices to enable collaborative care and advanced interventional endoscopic treatments.

1 investor

Gastro Health is a medical group of board-certified physicians and advanced practitioners specializing in gastrointestinal disorders, nutrition, and digestive health. The group provides comprehensive care including evaluation, treatment, surgery, colorectal procedures, infusion services, diagnostic studies, nutrition therapy, and weight loss programs.

1 investor

Syndeio Biosciences (Gate Neurosciences) is a synapse-focused biotech developing drug candidates for neuropsychiatric, mental health, and cognitive disorders such as depression, Alzheimer's, and schizophrenia. Its pipeline includes NMDA-receptor positive allosteric modulators like zelquistinel and apimostinel, supported by a proprietary synapse pharmacology platform originating from a Stanford University laboratory.

1 investor

Gather Group builds a platform that coordinates personal care teams—family, friends, and caregivers—to support patients through care transitions and help them enact their recovery plans. The platform targets hospitals, GPs, and rehabilitation facilities seeking to improve patient outcomes by shifting care coordination from individual self-management to a team-based approach.

1 investor

Gavi is a public-private partnership that funds vaccination programs in developing countries through contributions from governments, foundations, corporations, and private donors. The organization mobilizes resources to provide vaccine access and shape vaccine markets in supported nations.

1 investor

Seattle's LGBTQ+ Center is a community organization providing health services, wellness programs, arts initiatives, and resource navigation for LGBTQ individuals in the Seattle area. The center operates as a hub offering HIV/STI testing, PrEP navigation, healthcare support, youth programs, and cultural programming.

1 investor

CcHUB Growth Capital is an early-stage venture fund investing between ₦10 million and ₦30 million in seed and early-stage for-profit technology startups building solutions to local challenges in Nigeria. It provides funding, business advisory, and network connections to help portfolio companies scale and attract follow-on funding.

1 investor

GeBBS provides revenue cycle management and business process outsourcing services to healthcare organizations, with emphasis on HIPAA compliance, data security, and business continuity planning.

1 investor

GEM Health provides access to specialty healthcare, covering diagnosis, treatment, and ongoing support for patients. Its initial focus is sleep apnea, a condition where a large share of people remain undiagnosed and untreated.

1 investor

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.

1 investor

GenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.

1 investor

Gene Solutions is a biotechnology company that develops genetic testing solutions using Next-Generation Sequencing and artificial intelligence for reproductive health, clinical oncology, and multi-cancer screening. The company serves healthcare providers and patients seeking precision medicine through advanced genomic profiling and early cancer detection.

1 investor

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types. The company develops molecular signatures and liquid biopsy solutions for biopharma, diagnostics, and CRO partners.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor

General Neuro develops NeuroLingo, a tool used to support decoding, reading, and phonological awareness for children with dyslexia during Orton-Gillingham tutoring.

1 investor

GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations. It helps GPs deliver structured, evidence-based management plans for chronic disease prevention and health optimization without adding administrative burden.

1 investor

Generate Life Sciences was a reproductive, newborn stem cell, and genetic services company offering products and services to help families grow and protect their families. It has been acquired by CooperSurgical.

1 investor

GeneTech provides non-invasive prenatal testing (NIPT) using fetal cell-free DNA from maternal blood, along with clinical laboratory testing services, offered to certified medical institutions in Japan. It introduced NIPT in Japan in 2013 and runs a domestic analysis lab, serving pregnant patients and their families through partner hospitals.

1 investor

Genetica is an artificial intelligence-powered genetic testing company that analyzes hundreds of genes to provide scientific insights about physical traits, behavior, intelligence, and health risks for Asian populations. The company partners with leading genome sequencing organizations and aims to optimize personal development plans and protect individual and family health.

1 investor

Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.

1 investor

GenieBiome (G-NiiB) develops microbiome-modifying technology and therapeutic candidates supported by clinical trials, using next-generation sequencing. The company focuses on treating human diseases through microbiome-based solutions.

1 investor

GeniusVets provides a marketing program for veterinary practices, including websites, search engine marketing, content, and a directory that helps pet owners find local vets. It serves veterinarians and veterinary clinics in the animal health industry.

1 investor

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

1 investor